Relationship between Polymorphism in the Angiotensinogen, Angiotensin-Converting Enzyme or Angiotensin II Receptor and Renal Progression in Japanese NIDDM Patients

Publisher： Karger

E-ISSN： 2235-3186|82|2|139-144

ISSN： 1660-8151

Source： Nephron, Vol.82, Iss.2, 1999-06, pp. : 139-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polymorphism of the Angiotensin-Converting Enzyme Gene in End-Stage Renal Failure Patients

By  

Nephron, Vol. 85, Iss. 1, 2000-04 ,pp. : 54-59

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Diabetic Albuminuria in Patients with NIDDM Followed Up for 9 Years

By  

Nephron, Vol. 80, Iss. 1, 1998-09 ,pp. : 17-24

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors but Not Angiotensin II AT 1 Receptor Antagonists Affect Erythropoiesis in Patients with Anemia of End-Stage Renal Disease

By  

Nephron, Vol. 81, Iss. 1, 1999-01 ,pp. : 106-108

Karger

Access to resources Recommend Favorite

Comparison between the Angiotensin II Receptor Antagonist Candesartan Cilexetil and the Angiotensin-Converting Enzyme Inhibitor Trandolapril in Microalbuminuria of Patients with Early Diabetic Nephropathy

By  

Nephron, Vol. 86, Iss. 2, 2000-09 ,pp. : 247-247

Karger

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Inhibitor, Angiotensin II Receptor Antagonist and Calcium Antagonist on Urinary Podocytes in Patients with IgA Nephropathy

By  

American Journal of Nephrology, Vol. 20, Iss. 5, 2000-11 ,pp. : 373-379

Karger

Access to resources Recommend Favorite